Biosimilars and the FDA Guidance Documents – a discussion at Personalized Medicine TV – Video

Posted: March 1, 2012 at 10:51 am



24-02-2012 18:53 In February 2012, the FDA published 3 Guidance documents for biosimilars. Under the Biologics Price Competition and Innovation Act (BPCI Act), a biological product may be demonstrated to be "biosimilar" if data show that, among other things, the product is "highly similar" to an already-approved biological product. George Dranitsaris discusses the market and challenges of biosimilars.

Read the rest here:
Biosimilars and the FDA Guidance Documents - a discussion at Personalized Medicine TV - Video

Related Posts

Comments are closed.

Archives